Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials

Guofeng Ma(Capital Medical University), Kejing Ying(Sir Run Run Shaw Hospital), Ruifeng Zhang(Sir Run Run Shaw Hospital), Dan Wang(Tianjin University of Traditional Chinese Medicine), Xiaohong Wu(Sir Run Run Shaw Hospital)
Thrombosis Research
February 12, 2015
Cited by 24


Related Papers